| Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 3.8K |
| Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) | Nature Reviews Gastroenterology and Hepatology | 2016 | 618 |
| Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol | European Heart Journal | 2016 | 361 |
| Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries | JAMA - Journal of the American Medical Association | 2016 | 308 |
| Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes | Oncogene | 2016 | 293 |
| Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial | Lancet Oncology, The | 2016 | 253 |
| A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction | Annals of Oncology | 2016 | 200 |
| Population-Based Colonoscopy Screening for Colorectal Cancer: A Randomized Clinical Trial | JAMA Internal Medicine | 2016 | 170 |
| Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial | Lancet Oncology, The | 2016 | 162 |
| Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study | The Lancet Gastroenterology and Hepatology | 2016 | 160 |
| Referral criteria for outpatient specialty palliative cancer care: an international consensus | Lancet Oncology, The | 2016 | 136 |
| 15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau | British Journal of Haematology | 2016 | 118 |
| Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer | Annals of Oncology | 2016 | 100 |
| Robot-assisted versus open radical hysterectomy: A multi-institutional experience for early-stage cervical cancer | European Journal of Surgical Oncology | 2016 | 95 |
| Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome | JCI Insight | 2016 | 93 |
| Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase | Gynecologic Oncology | 2016 | 93 |
| No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing | Journal of Medical Genetics | 2016 | 83 |
| Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study | Acta Oncológica | 2016 | 82 |
| Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer | Clinical Nutrition | 2016 | 81 |
| MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer | Oncotarget | 2016 | 73 |
| Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA) | Annals of Oncology | 2016 | 67 |
| Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma | Blood | 2016 | 59 |
| Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET) | Annals of Oncology | 2016 | 55 |
| Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only | Pediatric Blood and Cancer | 2016 | 53 |
| Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis | Molecular Oncology | 2016 | 52 |
